BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma.

ABSTRACT:

SUBMITTER: Gutmair K 

PROVIDER: S-EPMC12127632 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature